Literature DB >> 35319300

Identification of Periosteal Osteogenic Progenitors in Jawbone.

Y Ding1, C Mo2, J Geng1, J Li1, Y Sun1.   

Abstract

Unlike long bones, jawbone development is mainly accomplished by intramembranous ossification resulting from the differentiation of periosteal progenitor cells. However, the spatiotemporal ontogeny of periosteal progenitor cells during jawbone development and repair remains elusive. In this study, we mapped the transcriptional landscape of the human jawbone periosteum at single-cell resolution and identified a cathepsin K (Ctsk)+ periosteal subset. Lineage tracing analysis indicated that Ctsk-Cre-labeled periosteal cells could make contributions to jawbone development. However, different from the periosteal-specific location of Ctsk+ cells in long bone, we also identified Ctsk+ stromal cells in jawbone marrow and implied the heterogeneity of jawbone Ctsk+ hierarchy. In further analysis of the periosteal progenitor cell subset of heterogeneous Ctsk+ hierarchy, we identified a unique Ctsk+Ly6a+ subset of cells. The additional marker Ly6a helped to further confine the progenitor subset to the jawbone periosteum and was nearly undetectable in the bone marrow. Defects in the jawbone could activate the migration and osteogenic differentiation of Ctsk+Ly6a+ cells. Local ablation of Ctsk+ cells by diphtheria reduced the number of Ctsk+Ly6a+ cells and delayed the repair of the bone defect. Taken together, we identify a novel periosteal osteogenic progenitor subset that is active in jawbone osteogenesis and healing.

Entities:  

Keywords:  cathepsin K; jaw; osteogenic differentiation; periosteum; single-cell analysis; skeletal stem cells

Mesh:

Year:  2022        PMID: 35319300     DOI: 10.1177/00220345221084200

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   8.924


  1 in total

Review 1.  Insights into skeletal stem cells.

Authors:  Qiwen Li; Ruoshi Xu; Kexin Lei; Quan Yuan
Journal:  Bone Res       Date:  2022-10-19       Impact factor: 13.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.